Using Harvested Dental Stem Cells

Board takeaway

• Counsel: Tell families that banking a tooth’s stem cells does not guarantee a usable future treatment.
• Current availability: The 2026 AAPD policy acknowledges promising research and human trials while stating that treatment using harvested dental stem cells is not currently available.
• Consent: Discuss collection, storage, viability, uncertain benefit, and informed consent without promising later cures.

Separate banking, research, and treatment

• The policy concerns stem cells harvested from teeth or dental follicles for possible regenerative therapy.
• Autologous use means returning cells to the same person; allogeneic use means cells come from another person.
• Laboratory potential, early human research, and an established clinical treatment are different levels of evidence.

Banking is not established treatment

Cell sources and biologic rationale

• Dental stem cells form a small population of mesenchymal stem cells (MSC) within specialized dental tissues.
• Sources/types: dental pulp (DPSC), exfoliated primary-tooth pulp (SHED), periodontal ligament (PDLSC), apical papilla (SCAP), and dental follicle cells.
• DPSC are accessible and have neural crest origins, supporting differentiation potential beyond dental tissues.
• Features attracting research: self-renewal, multiple differentiation pathways, immunomodulation, relatively low immunogenicity, regenerative/neurogenic potential, and expansion in culture with relative genomic stability.
• These properties provide a biologic rationale; they do not prove that an individual child's banked cells will be clinically useful.

Applications and limits of evidence

• Laboratory, animal, and in vivo work supports investigation of pulp regeneration and scaffold-based approaches.
• Potential dental applications include bone, periodontal, and endodontic regeneration, damaged-tissue repair, and future tooth generation.
• Nondental research includes neurologic disease, stroke, and immune-related conditions.
• A periodontitis DPSC trial showed encouraging outcomes, but results varied, generalizability was limited, and allogeneic-cell concerns remained.
• SHED showed preliminary promise for a nondental condition in a small initial safety-phase trial; this is not definitive efficacy evidence.
• Bone marrow transplantation is an established adult stem cell application cited for context. Its success cannot be transferred to harvested dental cells.

Counsel before harvesting or banking

• Potential collection sources discussed include exfoliating primary-tooth pulp, surgically removed third molars, periodontal ligament, and gingival fibroblasts.
• Proper securing and storage are necessary to preserve proliferation and differentiation potential. Accessibility alone does not assure viability.
• Explain the distinction between banking, experimental clinical research, and available treatment; avoid promising future disease treatment.
• Use appropriate informed consent and maintain ethical integrity throughout procurement.
• This policy does not recommend routine banking or extraction solely to obtain cells. Its discussion of possible tissue sources is not an extraction indication.
• For evolving research, the policy directs clinicians to NIH/National Library of Medicine trial resources.

Common board traps

Answer aloud

Does banking stem cells from a primary tooth guarantee future treatment?

No. The 2026 AAPD policy describes uncertain future usefulness and no currently available harvested-dental-cell treatment.

• Collection/storage must preserve viable cells and their differentiation potential.
• Explain the difference between banking, research, and available treatment.
• Obtain appropriate informed consent without promises of cures.

Does promising periodontitis stem-cell research justify routine treatment or extraction solely for banking?

No. Preliminary research does not establish routine therapy or an extraction indication.

• Periodontitis trial results varied and had limited generalizability/allogeneic concerns.
• Listed tissue sources are possible collection sources, not recommendations to extract healthy teeth.
• Bone marrow transplantation success cannot be transferred to harvested dental cells.